TY - JOUR
T1 - Risk Prediction Tools to Improve Patient Selection for Carotid Endarterectomy among Patients with Asymptomatic Carotid Stenosis
AU - Keyhani, Salomeh
AU - Madden, Erin
AU - Cheng, Eric M.
AU - Bravata, Dawn M.
AU - Halm, Ethan
AU - Austin, Peter C.
AU - Ghasemiesfe, Mehrnaz
AU - Abraham, Ann S.
AU - Zhang, Alysandra J.
AU - Johanning, Jason M.
N1 - Funding Information:
Concept and design: Keyhani, Madden, Cheng, Johanning. Acquisition, analysis, or interpretation of data: Keyhani, Madden, Cheng, Bravata, Halm, Austin, Ghasemiesfe, Abraham, Zhang. Drafting of the manuscript: Keyhani, Madden, Ghasemiesfe, Abraham. Critical revision of the manuscript for important intellectual content: Keyhani, Madden, Cheng, Bravata, Halm, Austin, Abraham, Zhang, Johanning. Statistical analysis: Madden, Bravata. Obtained funding: Keyhani, Cheng, Bravata. Administrative, technical, or material support: Ghasemiesfe, Abraham, Zhang, Johanning. Supervision: Keyhani, Halm, Johanning. Conflict of Interest Disclosures: Dr Cheng reported having received grants from the National Institutes of Health (NIH) during before or during the conduct of the study. Dr Bravata reported having received grants from the NIH before or during the conduct of the study. Dr Johanning reported a patent to Frailty Assessment pending. No other disclosures were reported. Funding/ Support: This project was supported by grant R01 HL114563-01A1 from the National Institute of Health and by Quality Enhancement Research Initiative grant 1IP1HX001994 from the Veterans Administration Health Services Research & Development. Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Meeting Presentation: This study was presented at the 2018 Annual Meeting of the Association of VA Surgeons; May 8, 2018; Miami, Florida.
Publisher Copyright:
© 2019 American Medical Association. All rights reserved.
PY - 2019/4
Y1 - 2019/4
N2 - Importance: Randomized clinical trials have demonstrated that patients with asymptomatic carotid stenosis are eligible for carotid endarterectomy (CEA) if the 30-day surgical complication rate is less than 3% and the patient's life expectancy is at least 5 years. Objective: To develop a risk prediction tool to improve patient selection for CEA among patients with asymptomatic carotid stenosis. Design, Setting, and Participants: In this cohort study, veterans 65 years and older who received both carotid imaging and CEA in the Veterans Administration between January 1, 2005, and December 31, 2009 (n = 2325) were followed up for 5 years. Data were analyzed from January 2005 to December 2015. A risk prediction tool (the Carotid Mortality Index [CMI]) based on 23 candidate variables identified in the literature was developed using Veterans Administration and Medicare data. A simpler model based on the number of 4 key comorbidities that were prevalent and strongly associated with 5-year mortality was also developed (any cancer in the past 5 years, chronic obstructive pulmonary disease, congestive heart failure, and chronic kidney disease [the 4C model]). Model performance was assessed using measures of discrimination (eg, area under the curve [AUC]) and calibration. Internal validation was performed by correcting for optimism using 500 bootstrapped samples. Main Outcome and Measure: Five-year mortality. Results: Among 2325 veterans, the mean (SD) age was 73.74 (5.92) years. The cohort was predominantly male (98.8%) and of white race/ethnicity (94.4%). Overall, 29.5% (n = 687) of patients died within 5 years of CEA. On the basis of a backward selection algorithm, 9 patient characteristics were selected (age, chronic kidney disease, diabetes, chronic obstructive pulmonary disease, any cancer diagnosis in the past 5 years, congestive heart failure, atrial fibrillation, remote stroke or transient ischemic attack, and body mass index) for the final logistic model, which yielded an optimism-corrected AUC of 0.687 for the CMI. The 4C model had slightly worse discrimination (AUC, 0.657) compared with the CMI model; however, the calibration curve was similar to the full model in most of the range of predicted probabilities. Conclusions and Relevance: According to results of this study, use of the CMI or the simpler 4C model may improve patient selection for CEA among patients with asymptomatic carotid stenosis.
AB - Importance: Randomized clinical trials have demonstrated that patients with asymptomatic carotid stenosis are eligible for carotid endarterectomy (CEA) if the 30-day surgical complication rate is less than 3% and the patient's life expectancy is at least 5 years. Objective: To develop a risk prediction tool to improve patient selection for CEA among patients with asymptomatic carotid stenosis. Design, Setting, and Participants: In this cohort study, veterans 65 years and older who received both carotid imaging and CEA in the Veterans Administration between January 1, 2005, and December 31, 2009 (n = 2325) were followed up for 5 years. Data were analyzed from January 2005 to December 2015. A risk prediction tool (the Carotid Mortality Index [CMI]) based on 23 candidate variables identified in the literature was developed using Veterans Administration and Medicare data. A simpler model based on the number of 4 key comorbidities that were prevalent and strongly associated with 5-year mortality was also developed (any cancer in the past 5 years, chronic obstructive pulmonary disease, congestive heart failure, and chronic kidney disease [the 4C model]). Model performance was assessed using measures of discrimination (eg, area under the curve [AUC]) and calibration. Internal validation was performed by correcting for optimism using 500 bootstrapped samples. Main Outcome and Measure: Five-year mortality. Results: Among 2325 veterans, the mean (SD) age was 73.74 (5.92) years. The cohort was predominantly male (98.8%) and of white race/ethnicity (94.4%). Overall, 29.5% (n = 687) of patients died within 5 years of CEA. On the basis of a backward selection algorithm, 9 patient characteristics were selected (age, chronic kidney disease, diabetes, chronic obstructive pulmonary disease, any cancer diagnosis in the past 5 years, congestive heart failure, atrial fibrillation, remote stroke or transient ischemic attack, and body mass index) for the final logistic model, which yielded an optimism-corrected AUC of 0.687 for the CMI. The 4C model had slightly worse discrimination (AUC, 0.657) compared with the CMI model; however, the calibration curve was similar to the full model in most of the range of predicted probabilities. Conclusions and Relevance: According to results of this study, use of the CMI or the simpler 4C model may improve patient selection for CEA among patients with asymptomatic carotid stenosis.
UR - http://www.scopus.com/inward/record.url?scp=85059940586&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059940586&partnerID=8YFLogxK
U2 - 10.1001/jamasurg.2018.5119
DO - 10.1001/jamasurg.2018.5119
M3 - Article
C2 - 30624562
AN - SCOPUS:85059940586
SN - 2168-6254
VL - 154
SP - 336
EP - 344
JO - JAMA Surgery
JF - JAMA Surgery
IS - 4
ER -